News, Pressemitteilungen, Events & Interviews:

  • March 2021

    March 2021

    04/14/2021 - CACEIS Regulatory Watch Newsletter

  • February 2021

    February 2021

    03/17/2021 - CACEIS Regulatory Watch Newsletter

  • EMIR: possible solutions for difficulties mandatory clearing

    EMIR: possible solutions for difficulties mandatory clearing

    02/11/2021 - Recital 26 of EMIR expressly acknowledged that to avoid the likely negative impact of such a requirement on the retirement income of future pensioners, the clearing obligation should not apply to pension schemes until a suitable technical solution for the posting of non-cash collateral as variation margin had been developed by Central Counterparties to address pension funds' lack of cash for use as collateral.

  • January 2021

    January 2021

    02/10/2021 - CACEIS Regulatory Watch Newsletter

  • EMIR: mandatory clearing poses difficulties for PSA

    EMIR: mandatory clearing poses difficulties for PSA

    02/05/2021 - On 17th December 2020, the European Securities and Markets Authority (ESMA) issued its second report on the clearing solutions for Pension Scheme Arrangements under EMIR.

  • December 2020

    December 2020

    01/18/2021 - CACEIS Regulatory Watch Newsletter

  • EMIR clearing obligation: the deadline is approaching

    EMIR clearing obligation: the deadline is approaching

    11/19/2018 - Since June 2016, mandatory clearing of OTC derivatives imposed by EMIR has gradually increased for a large proportion of financial counterparties. It will become a reality for Class 4 counterparties on 21st December 2018 and Class 3 counterparties on 21st June 2019, two years after the date initially set.

  • EMIR: Exchange of collateral for uncleared OTC derivatives

    EMIR: Exchange of collateral for uncleared OTC derivatives

    05/25/2017 - On 15th December 2016, the European Commission published the delegated regulation of 4th October 2016 on over-the-counter derivatives and established a requirement to exchange variation and/or initial margins on OTC derivatives not cleared by a central counterparty.